Literature DB >> 29975360

Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.

Paweł Wójciak1, Janusz Rybakowski1.   

Abstract

Negative symptoms of schizophrenia constitute a serious diagnostic and therapeutic problem. They substantially account for the impairment of health, social functioning and quality of life whereas treatment is difficult. In this paper the development of the concept of schizophrenia and negative symptoms is presented. The models of positive and negative symptoms, introduced in the 1980's by Timothy Crow and Nancy Andreasen, and William Carpenter's concept of so-called deficit syndrome with the criteria of the division of negative symptoms into the primary and secondary, are discussed. Current views on the pathogenesis of negative symptoms are shown with reference to neuroimaging studies, neurotransmitter alterations, neuropsychological deficits, genetic, immunological and epidemiological studies. A subsection is devoted to the diagnostics tools for negative symptoms. Chronologically, they are divided into scales of the 1st and 2nd generation. The first generation includes: the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS), the Positive and Negative Syndrome Scale (PANSS), the Schedule for the Deficit Syndrome (SDS), and the Proxy for Deficit Syndrome. The second generation scales, developed as a result of the recommendation by American experts in 2006, include: the Brief Negative Syndrome Scale (BNSS) and the Clinical Assessment Interview for Negative Symptoms (CAINS), also the self-assessment scales: the Motivation and Pleasure Scale - Self Report (MAP-SR) and the Self-assessment of Negative Symptoms (SNS). The BNSS and the SNS scales, whose Polish versions were elaborated in the Department of Adult Psychiatry of Poznan University of Medical Sciences, are discussed in-depth.

Entities:  

Keywords:  negative symptoms; pathogenesis; schizophrenia

Mesh:

Year:  2018        PMID: 29975360     DOI: 10.12740/PP/70610

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  3 in total

1.  Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.

Authors:  Shuochi Wei; Dongmei Wang; Huixia Zhou; Luyao Xia; Yang Tian; Qilong Dai; Rongrong Zhu; Wenjia Wang; Dachun Chen; Meihong Xiu; Li Wang; Xiangyang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-26       Impact factor: 5.760

2.  Role of Polyinosinic:Polycytidylic Acid-Induced Maternal Immune Activation and Subsequent Immune Challenge in the Behaviour and Microglial Cell Trajectory in Adult Offspring: A Study of the Neurodevelopmental Model of Schizophrenia.

Authors:  Katarzyna Chamera; Ewa Trojan; Katarzyna Kotarska; Magdalena Szuster-Głuszczak; Natalia Bryniarska; Kinga Tylek; Agnieszka Basta-Kaim
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

3.  Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of Schizophrenia.

Authors:  Lorena García-Fernández; Verónica Romero-Ferreiro; Luis Sánchez-Pastor; Mónica Dompablo; Isabel Martínez-Gras; Juan Manuel Espejo-Saavedra; David Rentero; Ana Isabel Aparicio; Miguel Angel Alvarez-Mon; Guillermo Lahera; Jimmy Lee; Jose Luis Santos; Roberto Rodriguez-Jimenez
Journal:  J Clin Med       Date:  2022-02-14       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.